Ipsen: 2018 net income up 43%
(CercleFinance.com) - Ipsen has published 2018 net income that is up 42.
6% at 389.1 million euros, or 4.68 euros per share, and will propose the payment of a dividend of one euro per share, unchanged compared to the previous year.
The pharmaceutical laboratory has achieved an operating margin of 29.7%, up 3.3 points, for sales growth of 16.6% (+20.1% at constant exchange rates) to 2,224.8 million euros, boosted by its specialty medicine.
The group targets 2019 sales growth of over 13% at constant exchange rates, with an operating margin of approximately 31% of sales (excluding additional growth investments within its R&D portfolio).
Copyright (c) 2019 CercleFinance.com. All rights reserved.
6% at 389.1 million euros, or 4.68 euros per share, and will propose the payment of a dividend of one euro per share, unchanged compared to the previous year.
The pharmaceutical laboratory has achieved an operating margin of 29.7%, up 3.3 points, for sales growth of 16.6% (+20.1% at constant exchange rates) to 2,224.8 million euros, boosted by its specialty medicine.
The group targets 2019 sales growth of over 13% at constant exchange rates, with an operating margin of approximately 31% of sales (excluding additional growth investments within its R&D portfolio).
Copyright (c) 2019 CercleFinance.com. All rights reserved.